These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31180700)

  • 1. BDNF association study with obsessive-compulsive disorder, its clinical characteristics, and response to fluvoxamine-treatment in Iranian patients.
    Abdolhosseinzadeh S; Alizadeh N; Shams J; Asadi S; Ahmadiani A
    Exp Clin Psychopharmacol; 2020 Apr; 28(2):216-224. PubMed ID: 31180700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and pharmacogenetic study of glutamate transporter (SLC1A1) in Iranian patients with obsessive-compulsive disorder.
    Abdolhosseinzadeh S; Sina M; Ahmadiani A; Asadi S; Shams J
    J Clin Pharm Ther; 2019 Feb; 44(1):39-48. PubMed ID: 30315580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the brain-derived neurotrophic factor SNP rs2883187 in the phenotypic expression of obsessive-compulsive disorder.
    Tükel R; Ozata B; Oztürk N; Ertekin BA; Ertekin E; Direskeneli GS
    J Clin Neurosci; 2014 May; 21(5):790-3. PubMed ID: 24291483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association study between BDNF gene variants and Mexican patients with obsessive-compulsive disorder.
    Márquez L; Camarena B; Hernández S; Lóyzaga C; Vargas L; Nicolini H
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1600-5. PubMed ID: 23999029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the brain-derived neurotrophic factor (BDNF) val66met variant in the phenotypic expression of obsessive-compulsive disorder (OCD).
    Katerberg H; Lochner C; Cath DC; de Jonge P; Bochdanovits Z; Moolman-Smook JC; Hemmings SM; Carey PD; Stein DJ; Sondervan D; Boer JA; van Balkom AJ; Polman A; Heutink P
    Am J Med Genet B Neuropsychiatr Genet; 2009 Dec; 150B(8):1050-62. PubMed ID: 19219856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BDNF Val66Met polymorphism and plasma levels in Chinese Han population with obsessive-compulsive disorder and generalized anxiety disorder.
    Wang Y; Zhang H; Li Y; Wang Z; Fan Q; Yu S; Lin Z; Xiao Z
    J Affect Disord; 2015 Nov; 186():7-12. PubMed ID: 26209750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of HTR1A gene polymorphisms with obsessive-compulsive disorder and its treatment response: the influence of sex and clinical characteristics.
    Alizadeh N; Nosrat N; Jahani Z; Ahmadiani A; Asadi S; Shams J
    Int J Neurosci; 2019 Mar; 129(3):264-272. PubMed ID: 30232922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder.
    Alonso P; Gratacòs M; Menchón JM; Saiz-Ruiz J; Segalàs C; Baca-García E; Labad J; Fernández-Piqueras J; Real E; Vaquero C; Pérez M; Dolengevich H; González JR; Bayés M; de Cid R; Vallejo J; Estivill X
    Biol Psychiatry; 2008 Mar; 63(6):619-28. PubMed ID: 17884018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Brain-Derived Neurotrophic Factor (BDNF) Val66Met Polymorphism Associated with Obsessive-Compulsive Disorder? A Meta-Analysis.
    Wang S; Xu X; Yan P; Song M; Li J; Wang S
    Psychiatr Danub; 2019 Jun; 31(2):141-147. PubMed ID: 31291217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-derived neurotrophic factor gene Val66Met polymorphism and cognitive function in obsessive-compulsive disorder.
    Tükel R; Gürvit H; Ozata B; Oztürk N; Ertekin BA; Ertekin E; Baran B; Kalem SA; Büyükgök D; Direskeneli GS
    Am J Med Genet B Neuropsychiatr Genet; 2012 Oct; 159B(7):850-8. PubMed ID: 22911909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics.
    McDougle CJ; Goodman WK; Leckman JF; Lee NC; Heninger GR; Price LH
    Arch Gen Psychiatry; 1994 Apr; 51(4):302-8. PubMed ID: 8161290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BDNF gene and obsessive compulsive disorder risk, symptom dimensions and treatment response.
    Taj M J RJ; Ganesh S; Shukla T; Deolankar S; Nadella RK; Sen S; Purushottam M; Reddy YCJ; Jain S; Viswanath B
    Asian J Psychiatr; 2018 Dec; 38():65-69. PubMed ID: 29079096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parental obsessive-compulsive disorder as a prognostic factor in a year long fluvoxamine treatment in childhood and adolescent obsessive-compulsive disorder.
    Yaryura-Tobias JA; Grunes MS; Walz J; Neziroglu F
    Int Clin Psychopharmacol; 2000 May; 15(3):163-8. PubMed ID: 10870874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the functional serotonin transporter haplotype with familial form of obsessive compulsive disorder in Iranian patients.
    Rashidi FS; Ahmadipour E; Shiravand S; Ahmadiani A; Asadi S; Shams J
    Int J Psychiatry Clin Pract; 2018 Mar; 22(1):47-53. PubMed ID: 28691545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of the association of brain-derived neurotrophic factor Val66Met polymorphism with obsessive-compulsive disorder.
    Wang J; Zhang F; Zhu W; Liu Y; Zhou Z
    Acta Neuropsychiatr; 2015 Dec; 27(6):327-35. PubMed ID: 26503495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in the BDNF Val66Met polymorphism and response to cognitive-behavior therapy in obsessive-compulsive disorder.
    Fullana MA; Alonso P; Gratacòs M; Jaurrieta N; Jiménez-Murcia S; Segalàs C; Real E; Estivill X; Menchón JM
    Eur Psychiatry; 2012 Jul; 27(5):386-90. PubMed ID: 22153732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A large case-control study of common functional SLC6A4 and BDNF variants in obsessive-compulsive disorder.
    Wendland JR; Kruse MR; Cromer KR; Murphy DL
    Neuropsychopharmacology; 2007 Dec; 32(12):2543-51. PubMed ID: 17375136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serotonin receptor 2a haplotypes with obsessive-compulsive disorder and its treatment response in Iranian patients: a genetic and pharmacogenetic study.
    Sina M; Ahmadiani A; Asadi S; Shams J
    Neuropsychiatr Dis Treat; 2018; 14():1199-1209. PubMed ID: 29785111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of SLC1A1 gene polymorphism with obsessive compulsive disorder in a sample from southern India.
    Shukla T; Nadella RK; Taj M J RJ; Ganesh S; Nestadt G; Purushottam M; Jain S; Reddy YCJ; Viswanath B
    Exp Clin Psychopharmacol; 2020 Dec; 28(6):617-621. PubMed ID: 31985241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.